<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04670536</url>
  </required_header>
  <id_info>
    <org_study_id>0313</org_study_id>
    <nct_id>NCT04670536</nct_id>
  </id_info>
  <brief_title>The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems (PASS DEGEN)</brief_title>
  <acronym>PASS DEGEN</acronym>
  <official_title>The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicrea International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicrea International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-market clinical follow-up study aims to collect some data about the performance and&#xD;
      safety of MEDICREA's products to treat thoraco-lumbar degenerative diseases(PASS LP, PASS&#xD;
      DEGEN, and TULIP PRIME). This study is supporting the clinical evaluation report. In&#xD;
      addition, a subgroup is added to collect post-market clinical data on the use of TULIP&#xD;
      Genesis medical devices for both degenerative and deformity indications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion</measure>
    <time_frame>At 24months</time_frame>
    <description>The primary objective is defined as the ability of the implant to promote the stabilization and/or the fusion of the instrumented segments at the last follow-up. Measures the bone fusion thanks to the Xrays judged by the investigator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of the pain (VAS)</measure>
    <time_frame>Preoperative, and 1-6, 12 and 24 months postoperative</time_frame>
    <description>Score of the pain (to 0 (better) to 10 (worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life with ODI</measure>
    <time_frame>Preoperative, and 1-6, 12 and 24 months postoperative</time_frame>
    <description>Score of the pain (to 0 (better) to 50 (worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life with SF-12</measure>
    <time_frame>Preoperative, and 1-6, 12 and 24 months postoperative</time_frame>
    <description>Score of the SF-12 (to 0 (better) to 100 (worst)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications (AE/SAE)</measure>
    <time_frame>Preoperative, and 1-6, 12 and 24 months postoperative</time_frame>
    <description>list all complications to calculate the rate of intraoperative and postoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeons'satisfaction with these implants and instruments</measure>
    <time_frame>During the surgery and until the 24months postoperative visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fusion</measure>
    <time_frame>At the 1-6, and 12 months postoperative</time_frame>
    <description>The primary objective is defined as the ability of the implant to promote the stabilization</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Thoracolumbar Disc Degeneration</condition>
  <condition>Thoracolumbar Spondylolisthesis</condition>
  <condition>Spinal Deformity</condition>
  <condition>Spinal Degeneration</condition>
  <arm_group>
    <arm_group_label>PASS LP implants</arm_group_label>
    <description>Patient suffering from a spinal degenerative disease and who is operated with PASS LP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PASS Degen implants</arm_group_label>
    <description>Patient suffering from a spinal degenerative disease and who is operated with PASS DEGEN</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PASS Tulip PRIME implants</arm_group_label>
    <description>Patient suffering from a spinal degenerative disease and who is operated with PASS TULIP PRIME</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PASS Tulip GENESIS implants</arm_group_label>
    <description>Patient suffering from a deformity and who is operated with PASS TULIP GENESIS implant(s)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PASS LP implants</intervention_name>
    <description>Thoraco lumbar arthrodesis</description>
    <arm_group_label>PASS LP implants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PASS DEGEN</intervention_name>
    <description>Thoraco lumbar arthrodesis</description>
    <arm_group_label>PASS Degen implants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PASS TULIP PRIME</intervention_name>
    <description>Thoraco lumbar arthrodesis</description>
    <arm_group_label>PASS Tulip PRIME implants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PASS TULIP GENESIS</intervention_name>
    <description>Thoraco lumbar arthrodesis</description>
    <arm_group_label>PASS Tulip GENESIS implants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient suffering from a spinal degenerative disease or Patient suffering from a&#xD;
             deformity (who is operated only with PASS TULIP GENESIS implant(s))&#xD;
&#xD;
          -  Patient of at least 18 years old&#xD;
&#xD;
          -  Patient requiring spinal surgery for less than 4 levels for a spinal degenerative&#xD;
             disease OR more than 4 levels for a deformity disease&#xD;
&#xD;
          -  Patient implanted with MEDICREA's products, including at least PASS LP and/or PASS&#xD;
             Degen and/or PASS Tulip implants&#xD;
&#xD;
          -  Patient affiliated to a national insurance system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient unable or unwilling to sign and understand an informed consent form&#xD;
&#xD;
          -  Patient unable to complete a self-administered questionnaire&#xD;
&#xD;
          -  Patient presenting contra-indications to a Xray follow-up&#xD;
&#xD;
          -  Patient of more than 18 years old under a protection procedure&#xD;
&#xD;
          -  Patient judged as non-compliant by the investigator or not able to come back for&#xD;
             follow-up visits up to 2 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Caroline Leblanc</last_name>
    <phone>0472018787</phone>
    <email>clinicalstudy@medicrea.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Orthopole</name>
      <address>
        <city>Bruges</city>
        <zip>33520</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Boissière</last_name>
    </contact>
    <investigator>
      <last_name>Louis Boissière</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique des Cèdres</name>
      <address>
        <city>Cornebarrieu</city>
        <zip>31700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Hamel</last_name>
    </contact>
    <investigator>
      <last_name>Olivier Hamel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal Sabatier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital La Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aymeric Amelot</last_name>
    </contact>
    <investigator>
      <last_name>Aymeric Amelot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon LY. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. Spine J. 2008 Nov-Dec;8(6):968-74. doi: 10.1016/j.spinee.2007.11.006. Epub 2008 Jan 16.</citation>
    <PMID>18201937</PMID>
  </reference>
  <reference>
    <citation>Hägg O, Fritzell P, Nordwall A; Swedish Lumbar Spine Study Group. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J. 2003 Feb;12(1):12-20. Epub 2002 Oct 24.</citation>
    <PMID>12592542</PMID>
  </reference>
  <reference>
    <citation>Glassman SD, Carreon LY, Djurasovic M, Dimar JR, Johnson JR, Puno RM, Campbell MJ. Lumbar fusion outcomes stratified by specific diagnostic indication. Spine J. 2009 Jan-Feb;9(1):13-21. doi: 10.1016/j.spinee.2008.08.011. Epub 2008 Sep 19.</citation>
    <PMID>18805059</PMID>
  </reference>
  <reference>
    <citation>Fukuda K, Takemitsu M, Machida M, Asazuma T. Lumbosacral fixation using sacroiliac buttress screws: a modification to the Jackson technique with intrasacral rods. Scoliosis. 2014 Jul 12;9:8. doi: 10.1186/1748-7161-9-8. eCollection 2014.</citation>
    <PMID>25050132</PMID>
  </reference>
  <reference>
    <citation>Kim YJ, Lenke LG, Bridwell KH, Kim J, Cho SK, Cheh G, Yoon J. Proximal junctional kyphosis in adolescent idiopathic scoliosis after 3 different types of posterior segmental spinal instrumentation and fusions: incidence and risk factor analysis of 410 cases. Spine (Phila Pa 1976). 2007 Nov 15;32(24):2731-8.</citation>
    <PMID>18007253</PMID>
  </reference>
  <reference>
    <citation>Zenner J, Hitzl W, Meier O, Auffarth A, Koller H. Surgical outcomes of scoliosis surgery in Marfan syndrome. J Spinal Disord Tech. 2014 Feb;27(1):48-58. doi: 10.1097/BSD.0b013e31824de6f1.</citation>
    <PMID>22395338</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

